ASKA Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
6,919
9,574
5,462
14,761
11,346
10,982
Total Accounts Receivable
7,442
8,483
8,566
9,485
10,400
11,022
Inventories
9,231
11,375
11,125
10,683
11,868
14,005
Other Current Assets
2,523
2,758
1,725
2,129
2,175
1,694
Total Current Assets
26,115
32,190
26,878
37,059
35,792
37,829
Net Property, Plant & Equipment
12,400
13,103
13,801
12,829
12,091
13,573
Total Investments and Advances
8,885
9,191
8,962
10,490
13,135
11,052
Intangible Assets
695
543
3,296
3,491
3,334
15,332
Other Assets
1,392
3,016
3,148
747
743
1,828
Total Assets
51,269
58,933
57,478
66,126
66,235
82,194
ST Debt & Current Portion LT Debt
1,441
808
2,458
1,200
1,200
Accounts Payable
4,074
6,856
3,784
5,309
5,218
Income Tax Payable
43
632
81
1,570
-
Other Current Liabilities
3,671
6,578
4,669
8,174
7,796
Total Current Liabilities
9,229
14,874
10,992
16,253
14,214
Long-Term Debt
116
558
3,250
2,500
1,750
Provision for Risks & Charges
7,736
6,880
7,227
7,768
7,671
Deferred Taxes
1,782
890
1,393
1,508
1,138
Other Liabilities
247
44
48
92
39
Total Liabilities
17,328
22,356
21,517
26,613
23,674
Common Equity (Total)
33,906
36,577
35,961
39,511
42,559
Total Shareholders' Equity
33,906
36,577
35,961
39,511
42,559
Total Equity
33,941
36,577
35,961
39,511
42,559
Liabilities & Shareholders' Equity
51,269
58,933
57,478
66,124
66,233
Accumulated Minority Interest
35
-
-
-
-
About ASKA Pharmaceutical Co.
View Profile
